MAP2K7 and breast cancer: While we have previously shown that breast cancer factors also induce ERK1/2 phosphorylation acting through TGFβ-dependent and independent mechanisms, inhibition of MEK was not effective in preventing breast cancer factors-induced osteoclastogenesis [31].